ABSTRACT
symptoms. In the context of mild TBI (MTBI), the label postconcussional symptoms (PCS) is commonly applied to reported problems including difficulty with concentration and memory, irritability, depression and anxiety, and physical symptoms such as fatigue, headaches, dizziness. [1] Such symptoms are common in the first few days or weeks after injury, but typically improve and remit. However, in a minority these symptoms persist. [2] When lasting beyond three months post-MTBI, they are viewed as problematic and likely to be chronic [3] or even worsen [4] and have previously been viewed as resistant to treatment. [5] Although the term PCS is typically associated with MTBI, the same constellation of symptoms can be reported after more severe injuries, although their aetiology and course may differ. [6] With this caveat, "PCS" will be used here, operationally, to describe the set of self-reported persistent postconcussional or PCS-like symptoms across a spectrum of TBI severity.
There is growing evidence indicating that psychosocial factors influence the persistence of PCS after MTBI [7] [8] [9] [10] [11] and overlapping symptoms or outcomes such as anxiety, depression and employment status in studies including individuals with severe TBIs. [12, 13] Lishman [14] suggested that while direct effects of brain injury may contribute towards early PCS, persistence may increasingly involve broader psychosocial factors and mechanisms. Similar diathesis-stressor models have been described [15, 16] where symptoms are maintained via "vicious cycles" involving factors indirectly related or independent of any direct effects of brain injury. If this is the case then psychological approaches to management may be applicable and effective in helping address or manage symptoms across a continuous spectrum of TBI severity, including more-than-mild TBIs, acknowledging that the likelihood and degree of persisting difficulties related to brain injury increases as injury severity increases.
Although supported by expert opinion, [17] evidence for the effectiveness of cognitive-behavioural therapy (CBT) to tackle persistent PCS is limited. [18] Trials incorporating CBT for individuals with TBI have tended to focus on specific symptoms such as depression, [19] insomnia, [20] [21] Typically using single-case or case series designs, results do point to possible improvements in these domains using CBT. There is some support for prophylactic interventions in patients at risk for persistent PCS in some [22] but not all studies. [23] Only one RCT has specifically focussed on persistent PCS [24] randomising 20 individuals with mild-moderate TBI (seen on average between 5 and 6 years post-injury) to a waiting list group or an intensive neuropsychological rehabilitation treatment program (5 hours per week for 11 weeks) combining CBT and cognitive remediation. Improvements were demonstrated on a global symptom measure, in symptoms associated with anxiety and depression, and some measures of cognitive functioning (although not subjective functioning). The relative contribution of the CBT and cognitive remediation components could not be assessed and it is unclear whether improvement could be achieved using CBT alone.
The current study tested the impact of individual, formulation-driven CBT, without explicit cognitive remediation or cognitive rehabilitation. The study was conducted as a preliminary RCT (with waiting list control) delivered in the context of two outpatient brain injury services. Eligibility criteria were designed to help ensure that the results would be generalizable to routine clinical practice. It was predicted that individuals would report reduced PCS and greater quality of life and health status after receiving CBT when compared with those in the control group. Supplementary analyses examined the impact on specific domains of PCS and quality of life, such as symptoms associated with depression, PTSD, pain and fatigue.
METHODS
Participants were randomised to the immediate Intervention group or waiting list Control group: the latter were offered treatment at the end of the waiting list period. There was no financial incentive or other compensation offered to participate in the study. Ethical approval was received by the committees overseeing the two trial sites. The trial was registered with the International Standard Randomised Controlled Trial Number Register (ISRCTN49540320). Potential participants were screened for eligibility at an initial neuropsychiatric or multidisciplinary assessment, and offered a neuropsychological assessment and feedback session if this had not been completed previously. In the absence of consistent contemporaneous injury severity information from GCS or post-traumatic amnesia (PTA), the latter was retrospectively estimated at initial assessment(s) using the Rivermead protocol [30] which provides reasonable accuracy in terms of overall categorical classification of TBI severity. [31] Median PTA duration was 24 hours (Intervention: 30 hours, range 0-1440 hours; Control: 16 hours, range 0-1800 hours).
C
All eligible participants were invited to participate. After providing informed consent, but before randomization, participants completed the first (T1) set of outcome measures with the study therapist. Table 1 . There were no significant differences between the two groups at T1 on any minimisation variables (all p's > 0. 4) PTA duration did differ between the groups (Mann-Whitney U=225.5; p=0.44). subscale totals (>10).
Impact of Event Scale -Revised (IES-R) [37] 22-item measure of PTSD Total score (>32) [38] Checklist of Individual Strength (CIS20R) [39] 20-item measure of fatigue Total score (cut-off of ≥40 for the "subjective fatigue" subscale) [40] McGill Pain Questionnaire (MPQ) [ For the QOLAS, individuals are asked to identify their two greatest problems/issues in each of five different domains: physical health, cognitive problems, psychological issues, social issues, and daily activities. Each problem is rated on a 0-5 scale (from to "no problem" to "it could not be worse") and the items summed. Validity, reliability and sensitivity to change for the QOLAS has been shown in other clinical populations. [35, 44] With the exception of the EuroQol, higher scores on all of the outcome measures indicate a greater degree of symptoms, distress or impact. All measures were self-report and therefore non-blind.
Assessments were completed prior to randomization (T1) and at the end of treatment (Intervention arm) or after 4-months (Control arm) (T2).
Treatment methods: CBT format and content
The planned intervention comprised 12 weekly one-hour sessions of individual CBT, but the protocol allowed for longer inter-session intervals. Treatment was provided by the same therapist (SP), a clinical neuropsychologist with previous experience of CBT in the context of TBI, depression and chronic fatigue syndrome.
Given the heterogeneity of PCS, an individualised, formulation-driven approach within a semistructured protocol was used. Agenda-based sessions, collaborative target-setting and homework tasks were central features of treatment. Details of the intervention are described in more detail elsewhere [16] and in the supplementary online information. A session structure similar to that described by Miller and Mittenberg [45] was used. The first three sessions were broadly focussed on problem identification, psychoeducation based on a range of sources, socialising the patient to the CBT model, and formulation. Sessions 4-12 focussed on the individual target problems identified collaboratively with the therapist. In the final 3 sessions, time was increasingly focussed on relapse prevention and how to maintain therapeutic gains. Copies of the protocol and booklets are available from the authors on request.
Central to individual CBT case formulations were (a) that persistent PCS could be maintained or exacerbated by vicious cycles [15] (b) that these cycles could be understood by reciprocal relationships between thoughts, emotions and actions, and (c) that alleviation in symptoms, associated distress and functional limitations was possible by changing thinking and behaviour. Whilst it was recognised in the treatment protocol that persistent cognitive difficulties attributable to the injury might exist for some individuals (especially for more-than-mild injuries), [46] no attempt was made to provide explicit cognitive remediation or rehabilitation. With increasing injury severity and more-than-mild TBIs, psychological mechanisms were framed as likely to still play an important role in maintaining ongoing symptoms via "vicious cycles", presenting a therapeutic target for CBT to help reduce symptoms and their impact. Overt resistance to psychologically-orientated treatment did not appear to be a common issue for individuals completing the initial screening assessments but who did not wish to take part in the trial. Although the reasons for declining participation were not systemically collected, of the 21 individuals who declined, 9 were prepared to be referred for CBT outside the trial, and another 5 cited distance as an obstacle to attending regular treatment sessions.
Control waiting list group
Individuals randomised to the Control arm received a letter following randomisation with the date of an out-patient appointment to complete the T2 measures. Patients in this arm did not receive any form of additional information or psychological intervention from the service for the period that they were on the waiting list. 
Statistical Analyses
Analysis was planned on an intention-to-treat basis. In practice almost all individuals in the Intervention arm completed their course of CBT and T2 outcome measures: three individuals stopped after 8, 9 and 10 sessions respectively due to significant symptom improvement and a lack of outstanding treatment targets. Only one patient discontinued treatment after 6 sessions and was lost to follow up due to difficulties attending the sessions. No attempt was made to impute missing data for this one case.
Data were double-entered from the completed paper forms on to computer, and analysed using SPSS 15.0. For the main treatment effects, analysis of covariance (ANCOVA) was used, [47] comparing outcome between groups at T2 with T1 as a covariate: effect sizes are shown using partial eta squared and an estimate of Cohen's d (d ), calculated as the mean difference between the contrasts divided by square root of the mean squared error.
It was predicted that the Intervention arm would report fewer symptoms and better quality of life after CBT compared with those in the Control arm after their time on the waiting list. Given the exploratory nature of the study and the paucity of evidence from relevant previous controlled trials, primary outcome measures were analysed independently without correction for multiple comparisons.
For secondary outcomes, corrections for multiple comparisons were applied using the Benjamini and Hochberg method. [48] Mean duration of the T1-T2 interval for the Intervention arm was 29 weeks (SD=10. 
RESULTS
Data for the primary and secondary outcome measures at T1 (baseline) and T2 are shown in Table 3 .
The two groups were broadly similar at baseline in terms of symptoms and quality of life reported:
there were no significant differences between the Intervention and Control arms at T1 on any of the primary or secondary outcome measures (p>0.05) after correcting for multiple comparisons on the latter. Figure 2 ). For postconcussional symptoms (RPQ) the findings were only significant when using T1-T2 interval as a covariate (Table 4) .
No treatment effect was noted in terms of global functioning (BICRO-30). Previous research into broader community rehabilitation using the BICRO-39 has indicated individual scales may be more sensitive to change than the total score: [49] these scale scores are also given in Table 4 . Psychological
Well-Being and Socialising showed evidence of a treatment effect (the latter only when using T1-T2
interval as a covariate), with little overall change in the other subscales in either group. interval, for anxiety (HADS-A), fatigue (CIS20R), anger (STAXI-2) and a quality of life (EuroQol).
These results remained significant after correcting for multiple comparisons. No treatment effects were found for depression (HADS-D), symptoms associated with PTSD (IES-R) or pain (MPQ).
Examination of the data indicated that, where T1-T2 interval was a significant covariate, shorter intervals were associated with better outcomes. This is illustrated by the data for PCS symptom severity (RPQ) (Figure 3 ) after dividing the Intervention arm into those completing treatment more quickly (n=13) and slowly (n=12) based on a median T1-T2 interval split of 188/189 days. Those taking longer to complete CBT show little change while those who completed CBT more quickly demonstrate larger improvements. This was in contrast to the possibility that a longer interval might allow additional time for individuals to show recovery, and be associated with better outcomes.
FIGURE 3 AROUND HERE
Uncorrected post hoc t-tests on unadjusted means were completed to explore within-group changes from T1 to T2 on those measures showing a significant difference between the Intervention and Control conditions on ANCOVA at T2 after covarying for treatment duration. 
Factors moderating treatment effects
To explore the possible influence of other factors on improvements in the Intervention group, data from the QOLAS was examined, as it showed the largest effects of treatment. Those factors used as minimisation variables at randomisation were considered separately as additional categorical factors:
data stratified by these variables is shown in 
DISCUSSION
This study, consistent with positive findings from a previous RCT, [24] found that individual CBT improved the quality of life for patients with persistent postconcussional symptoms. CBT also appeared to be effective in alleviating postconcussional symptoms in those patients who completed treatment more quickly. Possible benefits on a range of secondary outcomes including anxiety, fatigue and anger were also noted, albeit only after treatment duration was considered as a covariate. Some outcome measures showed medium to large effect sizes from before to after treatment, although the mean scores of the CBT group indicated that a majority of patients were not symptom-or problemfree at the end of treatment (as with the previous trial [24] ), although 24% of treatment completers fell below a proposed clinical cut-off of 12 or less on the RPQ. [33] The current study also demonstrates that clinical improvement in PCS is possible using CBT without an explicit cognitive remediation component, and with a programme of only 12 hours of patient-therapist contact. Contrary to expectations, neither medicolegal status, injury severity nor length of time since injury had significant effects on improvements in the CBT group.
Of the outcome measures used, the QOLAS gave the most robust evidence for an effect of CBT, perhaps because it captured specific symptoms identified by the patient as directly relevant to their quality of life. Its identification of "key" problem areas also helped identify personal treatment targets for therapy, increasing its sensitivity to change and its clinical utility. The potential advantages for individualised patient reported outcome measures and their responsiveness to change has led to their appearance into brain injury rehabilitation via methods such as Goal Attainment Scaling. [49] Contrary to expectations that persistent symptoms are static or may even worsen with time, for symptoms and offering hope that change and improvement was possible. [50] There was no evidence for significant effects of treatment on depression or PTSD, both of which have been linked with PCS. [9] This may have been due to floor effects as less than 50% of individuals scored above clinical cut-offs on the HADS-Depression and RIES at the initial assessment. However, the results imply that general improvement in PCS and quality of life were not simply mediated by improved mood.
The impact of the time taken to complete CBT was noteworthy. Not using treatment duration as a covariate removed positive group differences for postconcussional symptoms (as measured by the RPQ), although those for quality of life (QOLAS and BICRO-Psychological Well-Being) remained.
Session frequency may be a factor, with evidence that increased intensity may be associated with better outcomes in psychological therapies in other areas, [51] although this may not always be the case. [52] Faster completion may also have indicated greater engagement to therapy. Although the large majority completed therapy, a longer time to complete the CBT sessions was often due to patients repeatedly cancelling and re-arranging appointments, perhaps reflecting lower commitment.
Whatever the source of this effect, it does indicate that there may be significant variability between individuals with persistent PCS in their treatment response to CBT. outcome in mild but not severe TBI. [8] Nonetheless, the null results for variables that might be expected to affect treatment outcomes suggests that they may not be major determinants of improvement in CBT, at least for the individuals seen in the current trial.
Study limitations
The variation in time taken to complete the sessions of CBT (with the CBT group taking longer to complete their treatment than the interval spent on waiting list in the control group) was undesirable, although the alternative of having a fixed assessment interval regardless of the completeness of treatment imposes its own difficulties. Use of a cross-over waiting list design complicates the controlled assessment of the maintenance of therapy benefits and longer-term outcome. Data on other variables that might have influenced outcomes (such as homework completion, or perceptions of the usefulness of treatment) were not collected.
Another limitation stems from the use of a single therapist combined with individualised treatment.
Although fitting the needs of patients, rather using a highly manualised protocol, generalisability of the findings may be limited by the therapist's expertise. Whilst typical of clinical practice, completion of study questionnaires given by the treating therapist may also contribute a potential response bias.
Future larger/multicentre studies may usefully include a measure of therapist competence and protocol adherence, and outcome measures given by a non-treating researcher.
Conclusions
The current trial adds to the sparse evidence that the impact of persistent PCS, especially on individuals' quality of life, can be ameliorated even for individuals sustaining more-than-mild TBIs.
Individual differences in treatment response were noted, as indicated by the impact of treatment 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 domains, and the impact of mood, rumination and worry; [3] and the possible effects of elements of perfectionism [4, 5] and reinvestment. [6] Where formulations identified overlap with relevant conditions such as anxiety and depression, cognitive-behavioural techniques used were based on the work of Beck, [7] and
Hawton and colleagues, [8] and utilised modifications for chronic fatigue syndrome, [9] PTSD [10] and perfectionism [5] when appropriate.
Behavioural components included work on sleep hygiene [8] and behavioural activation, [11] with a particular focus on making sustainable increases in activity over time avoiding "boomand-bust", [9] as well as addressing possible avoidance and procrastination [12] .
Cognitive approaches included negative automatic and dysfunctional thoughts records in responses to symptoms, explored through Socratic questioning, and challenged/tested particular through verbal reattribution techniques or behavioural experiments. A focus on 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
